TRPA1 and prostate carcinoma: This study showed that the antibacterial agent, triclostan, stimulated TRPA1 to mediate extracellular Ca2+ entry, thereby resulting in vascular endothelial growth factor (VEGF) secretion and prostate cancer cell proliferation [90].